Emergent BioSolutions Inc. (NYSE:EBS) today announced the beginning of a $50 million expansion to the company’s Camden fill/finish facility located in Baltimore, Md. The multi-year expansion is expected to be completed in 2021, and will significantly increase the company’s contract development and manufacturing capacity, redundancy, and flexibility. This expansion is also anticipated to create up to 60 new jobs in the next three years.
{iframe}https://globenewswire.com/news-release/2018/06/07/1518241/0/en/Emergent-BioSolutions-Announces-50-Million-Expansion-of-Baltimore-Fill-Finish-Facility.html{/iframe}